BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34899733)

  • 1. The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing.
    Wang Y; Xiao X; Chen S; Huang C; Zhou J; Dai E; Li Y; Liu L; Huang X; Gao Z; Wu C; Fang M; Gao C
    Front Immunol; 2021; 12():775461. PubMed ID: 34899733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of low levels of HBsAg and high levels of anti-HBs may increase risk of hepatocellular carcinoma in chronic hepatitis B patients with high HBV load.
    Jin ZZ; Jin FF; Liu X; Liu N; Wen F; Lou JL
    Braz J Infect Dis; 2019; 23(5):343-351. PubMed ID: 31542378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [S gene mutations in HBsAg/HBsAb double positive chronic hepatitis B patients].
    Zhang ZH; Peng J; Xia JB; Tian YJ; Jiang M; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):266-70. PubMed ID: 19403024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma.
    Zhang AY; Lai CL; Huang FY; Seto WK; Fung J; Wong DK; Yuen MF
    J Gastroenterol; 2017 Sep; 52(9):1064-1074. PubMed ID: 28353014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection.
    Usman Z; Mijočević H; Karimzadeh H; Däumer M; Al-Mathab M; Bazinet M; Frishman D; Vaillant A; Roggendorf M
    J Viral Hepat; 2019 Dec; 26(12):1454-1464. PubMed ID: 31323705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HBsAg mutation patterns with hepatitis B infection outcome: Asymptomatic carriers versus HCC/cirrhotic patients.
    Hosseini SY; Sanaei N; Fattahi MR; Malek-Hosseini SA; Sarvari J
    Ann Hepatol; 2019; 18(4):640-645. PubMed ID: 31105017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing revealed divergence in deletions of the preS region in the HBV genome between different HBV-related liver diseases.
    Jia J; Liang X; Chen S; Wang H; Li H; Fang M; Bai X; Wang Z; Wang M; Zhu S; Sun F; Gao C
    J Gen Virol; 2017 Nov; 98(11):2748-2758. PubMed ID: 29022863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.
    Bai X; Jia JA; Fang M; Chen S; Liang X; Zhu S; Zhang S; Feng J; Sun F; Gao C
    PLoS Genet; 2018 Feb; 14(2):e1007206. PubMed ID: 29474353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
    Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
    Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Quasispecies Patterns of Hepatitis B Virus to Predict Hepatocellular Carcinoma With Deep Sequencing and Machine Learning.
    Chen S; Zhang Z; Wang Y; Fang M; Zhou J; Li Y; Dai E; Feng Z; Wang H; Yang Z; Li Y; Huang X; Jia J; Li S; Huang C; Tong L; Xiao X; He Y; Duan Y; Zhu S; Gao C
    J Infect Dis; 2021 Jun; 223(11):1887-1896. PubMed ID: 33049037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers.
    Colson P; Borentain P; Motte A; Henry M; Moal V; Botta-Fridlund D; Tamalet C; Gérolami R
    Virology; 2007 Oct; 367(1):30-40. PubMed ID: 17573090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen.
    Wang YM; Ng WC; Lo SK
    J Gastroenterol; 1999 Oct; 34(5):600-6. PubMed ID: 10535488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete genome analysis of hepatitis B virus in Qinghai-Tibet plateau: the geographical distribution, genetic diversity, and co-existence of HBsAg and anti-HBs antibodies.
    Liu H; Shen L; Zhang S; Wang F; Zhang G; Yin Z; Qiu F; Liang X; Wang F; Bi S
    Virol J; 2020 Jun; 17(1):75. PubMed ID: 32532295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B.
    Liang Y; Yano Y; Putri WA; Mardian Y; Okada R; Tanahashi T; Murakami Y; Hayashi Y
    Mol Med Rep; 2018 Apr; 17(4):5528-5537. PubMed ID: 29393485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination.
    Galati G; De Vincentis A; Vespasiani-Gentilucci U; Gallo P; Vincenti D; Solmone MC; Dell'Unto C; Picardi A
    BMC Gastroenterol; 2014 May; 14():94. PubMed ID: 24885182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of tryptophan-truncated S quasispecies in treatment-naïve chronic hepatitis B patients.
    Dong H; Zhu Y; Shen Y; Xie S; He Y; Lu L
    J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34292864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.